Low-dose colchicine for secondary prevention of cardiovascular disease.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The objective of this study was to determine whether colchicine 0.5 mg/day can reduce the risk of cardiovascular events in patients with clinically stable coronary disease.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Am Coll Cardiol

Title: Journal of the American College of Cardiology

Publisher: Elsevier BV

ISSN (Electronic): 1558-3597

ISSN (Print): 0735-1097

Publication date (Electronic): Jan 29 2013

Volume: 61

Issue: 4

Affiliations

[1 ] Heart Care Western Australia, Perth, Western Australia, Australia. Electronic address: smnidorf@gmail.com.

[2 ] McMaster University, Hamilton, Ontario, Canada.

[3 ] Centre for Applied Statistics, University of Western Australia, Perth, Western Australia, Australia.

[4 ] Heart Research Institute of Western Australia, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

Article

Publisher Item ID: S0735-1097(12)05478-2

DOI: 10.1016/j.jacc.2012.10.027

PubMed ID: 23265346

SO-VID: c0e264de-e200-462b-bc39-9b0171d8c418

History

Data availability:

Comments

Comment on this article

scite_

Cited by 283

See all cited by

- Version 1